Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The product of the
ataxia-telangiectasia
gene (
ATM
) was identified by using an antiserum developed to a peptide corresponding to the deduced amino acid sequence. The
ATM protein
is a single, high-molecular weight protein predominantly confined to the nucleus of human fibroblasts, but is present in both nuclear and microsomal fractions from human lymphoblast cells and peripheral blood lymphocytes.
ATM protein
levels and localization remain constant throughout all stages of the cell cycle. Truncated
ATM protein
was not detected in lymphoblasts from
ataxia-telangiectasia
patients homozygous for mutations leading to premature protein termination. Exposure of normal human cells to gamma-irradiation and the radiomimetic drug neocarzinostatin had no effect on
ATM protein
levels, in contrast to a noted rise in p53 levels over the same time interval. These findings are consistent with a role for the
ATM protein
in ensuring the fidelity of DNA repair and cell cycle regulation following genome damage.
...
PMID:The ataxia-telangiectasia gene product, a constitutively expressed nuclear protein that is not up-regulated following genome damage. 905 Aug 66
Mutations in the
ATM
gene are responsible for the multisystem disorder
ataxia-telangiectasia
, characterized by neurodegeneration, immune deficiency and cancer predisposition. While no alternative splicing was identified within the coding region, the first four exons of the
ATM
gene, which fall within the 5'untranslated region (UTR), undergo extensive alternative splicing. We identified 12 different 5'UTRs that show considerable diversity in length and sequence contents. These mRNA leaders, which range from 150 to 884 nucleotides (nt), are expected to form variable secondary structures and contain different numbers of AUG codons. The longest 5'UTR contains a total of 18 AUGs upstream of the translation start site. The 3'UTR of 3590 nt is contained within a single 3'exon. Alternative polyadenylation results in 3'UTRs of varying lengths. These structural features suggest that
ATM
expression might be subject to complex post-transcriptional regulation, enabling rapid modulation of
ATM protein
level in response to environmental stimuli or alterations in cellular physiological states.
...
PMID:Ataxia-telangiectasia: structural diversity of untranslated sequences suggests complex post-transcriptional regulation of ATM gene expression. 910 47
The
ATM protein
has been implicated in pathways controlling cell cycle checkpoints, radiosensitivity, genetic instability, and aging. Expression of
ATM
fragments containing a leucine zipper motif in a human tumor cell line abrogated the S-phase checkpoint after ionizing irradiation and enhanced radiosensitivity and chromosomal breakage. These fragments did not abrogate irradiation-induced G1 or G2 checkpoints, suggesting that cell cycle checkpoint defects alone cannot account for chromosomal instability in
ataxia telangiectasia
(AT) cells. Expression of the carboxy-terminal portion of
ATM
, which contains the PI-3 kinase domain, complemented radiosensitivity and the S-phase checkpoint and reduced chromosomal breakage after irradiation in AT cells. These observations suggest that
ATM
function is dependent on interactions with itself or other proteins through the leucine zipper region and that the PI-3 kinase domain contains much of the significant activity of
ATM
.
...
PMID:Fragments of ATM which have dominant-negative or complementing activity. 912 50
The autosomal recessive human disorder
ataxia-telangiectasia
(
A-T
) was first described as a separate disease entity 40 years ago. It is a multisystem disease characterized by progressive cerebellar ataxia, oculocutaneous telangiectasia, radiosensitivity, predisposition to lymphoid malignancies and immunodeficiency, with defects in both cellular and humoral immunity. The pleiotropic nature of the clinical and cellular phenotype suggests that the gene product involved is important in maintaining stability of the genome but also plays a more general role in signal transduction. The chromosomal instability and radiosensitivity so characteristic of this disease appear to be related to defective activation of cell cycle checkpoints. Greater insight into the nature of the defect in
A-T
has been provided by the recent identification, by positional cloning, of the responsible gene,
ATM
. The
ATM
gene is related to a family of genes involved in cellular responses to DNA damage and/or cell cycle control. These genes encode large proteins containing a phosphatidylinositol 3-kinase domain, some of which have protein kinase activity. The mutations causing
A-T
completely inactivate or eliminate the
ATM protein
. This protein has been detected and localized to different subcellular compartments.
...
PMID:The genetic defect in ataxia-telangiectasia. 914 86
The recently cloned gene (
ATM
) mutated in the human genetic disorder
ataxia-telangiectasia
(
A-T
) is involved in DNA damage response at different cell cycle checkpoints and also appears to have a wider role in signal transduction. Antibodies prepared against peptides from the predicted protein sequence detected a approximately 350 kDa protein corresponding to the open reading frame, which was absent in 13/23
A-T
homozygotes. Subcellular fractionation, immunoelectronmicroscopy and immunofluorescence showed that the
ATM protein
is present in the nucleus and cytoplasmic vesicles. This distribution did not change after irradiation. We also provide evidence that
ATM protein
binds to p53 and this association is defective in
A-T
cells compatible with the defective p53 response in these cells. These results provide further support for a role for the
ATM protein
as a sensor of DNA damage and in a more general role in cell signalling, compatible with the broader phenotype of the syndrome.
...
PMID:Cellular localisation of the ataxia-telangiectasia (ATM) gene product and discrimination between mutated and normal forms. 915 Mar 58
A gene mutated in the human genetic disorder
ataxia-telangiectasia
(
A-T
),
ATM
, was recently identified by positional cloning.
ATM
is a member of the phosphatidylinositol-3-kinase superfamily, some of which are protein kinases and appear to have important roles in cell cycle control and radiation signal transduction. We describe herein, to our knowledge, for the first time, the cloning of a full-length cDNA for
ATM
and correction of multiple aspects of the radio-sensitive phenotype of
A-T
cells by transfection with this cDNA. Overexpression of
ATM
cDNA in
A-T
cells enhanced the survival of these cells in response to radiation exposure, decreased radiation-induced chromosome aberrations, reduced radio-resistant DNA synthesis, and partially corrected defective cell cycle checkpoints and induction of stress-activated protein kinase. This correction of the defects in
A-T
cells provides further evidence of the multiplicity of effector functions of the
ATM protein
and suggests possible approaches to gene therapy.
...
PMID:Isolation of full-length ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. 922 7
Ataxia-telangiectasia
(
A-T
) is an autosomal recessive disorder characterized by neurodegeneration, immunodeficiency, cancer predisposition, genome instability and radiation sensitivity. The cellular phenotype of
A-T
points to defects in signal transduction pathways involved in activation of cell cycle checkpoints by free radical damage, and other pathways that mediate the transmission of specific mitogenic stimuli. The product of the responsible gene,
ATM
, belongs to a family of large proteins that contribute to maintaining genome stability and cell cycle progression in various organisms. A recombinant vector that stably expresses a full-length
ATM protein
is a valuable tool for its functional analysis. We constructed and cloned a recombinant, full-length open reading frame of
ATM
using a combination of vectors and hosts that overcame an inherent instability of this sequence. Recombinant
ATM
was stably expressed in insect cells using a baculovirus vector, albeit at a low level, and in human
A-T
cells using an episomal expression vector. An amino-terminal FLAG epitope added to the protein allowed highly specific detection of the recombinant molecule by immunoblotting, immunoprecipitation and immunostaining, and its isolation using immunoaffinity. Similar to endogenous
ATM
, the recombinant protein is located mainly in the nucleus, with low levels in the cytoplasm. Ectopic expression of
ATM
in
A-T
cells restored normal sensitivity to ionizing radiation and the radiomimetic drug neocarzinostatin, and a normal pattern of post-irradiation DNA synthesis, which represents an S-phase checkpoint. These observations indicate that the recombinant, epitope-tagged protein is functional. Introduction into this molecule of a known
A-T
missense mutation, Glu2904Gly, resulted in apparent instability of the protein and inability to complement the
A-T
phenotype. These findings indicate that the physiological defects characteristic of
A-T
cells result from the absence of the
ATM protein
, and that this deficiency can be corrected by ectopic expression of this protein.
...
PMID:Recombinant ATM protein complements the cellular A-T phenotype. 924 51
Advances have been made in unravelling the molecular chains of cause and effect that determine cellular responses to radiotherapy, including cell cycle arrest, DNA repair and apoptosis. To begin with, cells must have mechanisms that enable them to sense DNA damage. Little was known about this until recently, when a DNA-protein kinase (DNA-PK) system for detecting radiation-induced strand breaks was described. The
ataxia telangiectasia (ATM)
gene has amino acid sequence similarities to DNA-PK, raising the possibility that the
ATM protein
also functions in some way as a sensor of DNA damage. However, just knowing the DNA damage is present is not enough. Signals must be transmitted via afferent biochemical pathways to proteins, such as p53, that determine which cellular responses are activated. The responses include cell cycle arrest, apoptosis and DNA repair, all of which relate closely to loss of clonogenic capacity and the outcome of treatment in our patients.
...
PMID:Molecular aspects of cellular responses to radiotherapy. 928 50
The autosomal recessive disorder
ataxia-telangiectasia
(AT) is highly pleiotropic. It is characterized by gradual loss of Purkinje cells in the cerebellum, leading to progressive neuromotor deterioration, immunodeficiency, developmental defects in specific tissues, profound predisposition to malignancy and acute sensitivity to ionizing radiation. AT cells show chromosomal instability, premature senesence, radiosensitivity and defects in cell cycle checkpoints activated by ionizing radiation. Several radiation induced pathways that regulate the cell cycle seem to be defective in AT cells, at least one of which is mediated by TP53. Extensive characterization of the cellular defects of AT cells, together with the recent isolation of the
ATM
gene, has provided some insight into the possible physiological roles of the
ATM protein
. Several lines of evidence, including the nature of the agents that elicit the hypersensitivity of AT cells, point to the possibility of a defect in the response to damage induced by oxidative stress, which affects various cellular macromolecules. The
ATM protein
might have a role in activating defence mechanisms against oxidative stress. This hypothesis broadens the previous concept of the AT defect and explains several aspects of the AT phenotype that cannot be accounted for by defective processing of DNA damage.
...
PMID:The ATM gene and protein: possible roles in genome surveillance, checkpoint controls and cellular defence against oxidative stress. 933 5
Gene mutations provide valuable clues to cellular metabolism. In humans such insights come mainly from genetic disorders.
Ataxia-telangiectasia
(
A-T
) and Nijmegen breakage syndrome (NBS) are two distinct but closely related, single gene disorders that highlight a complex junction of several signal transduction pathways. These pathways appear to control defense mechanisms against specific types of damage to cellular macromolecules, and probably regulate the processing of certain types of DNA damage or normal intermediates of DNA metabolism.
A-T
is characterized primarily by cerebellar degeneration, immunodeficiency, genome instability, clinical radiosensitivity, and cancer predisposition. NBS shares all these features except cerebellar deterioration. The cellular phenotypes of
A-T
and NBS are almost indistinguishable, however, and include chromosomal instability, radiosensitivity, and defects in cell cycle checkpoints normally induced by ionizing radiation. The recent identification of the gene responsible for
A-T
,
ATM
, has revealed its product to be a large, constitutively expressed phosphoprotein with a carboxy-terminal region similar to the catalytic domain of phosphatidylinositol 3-kinases (PI 3-kinases).
ATM
is a member of a family of proteins identified in various organisms, which share the PI 3-kinase domain and are involved in regulation of cell cycle progression and response to genotoxic agents. Some of these proteins, most notably the DNA-dependent protein kinase, have an associated protein kinase activity, and preliminary data indicate this activity in
ATM
as well. Mutations in
A-T
patients are null alleles that truncate or destabilize the
ATM protein
. Atm-deficient mice recapitulate the human phenotype with slower nervous-system degeneration. Two
ATM
interactors, c-Abl and p53, underscore its role in cellular responses to genotoxic stress. The complexity of
ATM
's structure and mode of action make it a paradigm of multifaceted signal transduction proteins involved in many physiological pathways via multiple protein-protein interactions. The as yet unknown NBS protein may be a component in an
ATM
-based complex, with a key role in sensing and processing specific DNA damage or intermediates and signaling their presence to the cell cycle machinery.
...
PMID:Ataxia-telangiectasia and the Nijmegen breakage syndrome: related disorders but genes apart. 944 10
<< Previous
1
2
3
4
5
6
7
8
9
10
Next >>